Tech Company Financing Transactions
Biobeat Technologies Funding Round
Biobeat Technologies, based in Boca Raton, secured $50 million from Ally Bridge Group, Elevage Medical Technologies and OrbiMed.
Transaction Overview
Company Name
Announced On
1/3/2026
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
Ally Bridge Group (Lead Investor)
Elevage Medical Technologies (Lead Investor)
OrbiMed (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand commercialization in the United States.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3651 FAU Boulevard 400
Boca Raton, FL 33431
USA
Boca Raton, FL 33431
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Biobeat is revolutionizing care with its groundbreaking advancements in diagnosis and management of hypertension. Our cuff-less blood pressure monitoring system enhances clinical decision-making and optimizes patient care by eliminating the stress and inconvenience of traditional methods.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Raymond Cohen
Chief Executive Officer
Arik Ishay
Browse more venture capital transactions:
Prev: 1/2/2026: Vyriad venture capital transaction
Next: 1/5/2026: Ballurh venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs